Funding for this research was provided by:
Chang Gung Medical Foundation (CMRPG3E0391/2/3)
Ministry of Science and Technology, Taiwan (106-2314-B-182-053-MY2)
Ministry of Health and Welfare (MOHW106-TDU-B-212-113005)
Received: 14 July 2020
Accepted: 21 April 2021
First Online: 4 May 2021
: The study was approved by the hospital’s Institutional Review Board (IRB numbers 104-6241B and 103-4707B). Because of the retrospective nature of the study, the need for informed consent was waived.
: Not applicable.
: NL is compensated by ACT Genomics, Co. Ltd. Y.-J.L., C-HC, KTT, H-CC, H-YL, and S-JC are employed by ACT Genomics, Co. Ltd.